143 related articles for article (PubMed ID: 30645056)
21. Lactoferrin receptor mediates apo- but not holo-lactoferrin internalization via clathrin-mediated endocytosis in trophoblasts.
Lopez V; Kelleher SL; Lonnerdal B
Biochem J; 2008 Apr; 411(2):271-8. PubMed ID: 18171326
[TBL] [Abstract][Full Text] [Related]
22. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
23. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
24. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Jpn J Cancer Res; 1997 Feb; 88(2):184-90. PubMed ID: 9119747
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery.
Song MM; Xu HL; Liang JX; Xiang HH; Liu R; Shen YX
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():904-911. PubMed ID: 28532109
[TBL] [Abstract][Full Text] [Related]
26. Nano-graphene oxide-manganese dioxide nanocomposites for overcoming tumor hypoxia and enhancing cancer radioisotope therapy.
Tao Y; Zhu L; Zhao Y; Yi X; Zhu L; Ge F; Mou X; Chen L; Sun L; Yang K
Nanoscale; 2018 Mar; 10(11):5114-5123. PubMed ID: 29487939
[TBL] [Abstract][Full Text] [Related]
27. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.
Luo B; Liang H; Zhang S; Qin X; Liu X; Liu W; Zeng F; Wu Y; Yang X
Int J Nanomedicine; 2015; 10():5805-17. PubMed ID: 26396514
[TBL] [Abstract][Full Text] [Related]
28. [In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
Wei MY; Zou Q; Wu CB; Xu YH
Yao Xue Xue Bao; 2015 Oct; 50(10):1272-9. PubMed ID: 26837173
[TBL] [Abstract][Full Text] [Related]
29. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
30. Protection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin.
Kuo YC; Wang CT
Biomaterials; 2014 Jul; 35(22):5954-64. PubMed ID: 24746790
[TBL] [Abstract][Full Text] [Related]
31. Apo- and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways.
Jiang R; Lönnerdal B
Int J Biochem Cell Biol; 2012 Jan; 44(1):91-100. PubMed ID: 22009034
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
[TBL] [Abstract][Full Text] [Related]
33. Physico-chemical properties of different forms of bovine lactoferrin.
Bokkhim H; Bansal N; Grøndahl L; Bhandari B
Food Chem; 2013 Dec; 141(3):3007-13. PubMed ID: 23871052
[TBL] [Abstract][Full Text] [Related]
34. pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study.
Silva JO; Fernandes RS; Lopes SC; Cardoso VN; Leite EA; Cassali GD; Marzola MC; Rubello D; Oliveira MC; de Barros AL
Mol Imaging Biol; 2016 Dec; 18(6):898-904. PubMed ID: 27172938
[TBL] [Abstract][Full Text] [Related]
35. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
36. Lactoferrin and anti-lactoferrin antibodies: effects of ironloading of lactoferrin on albumin extravasation in different tissues in rats.
Erga KS; Peen E; Tenstad O; Reed RK
Acta Physiol Scand; 2000 Sep; 170(1):11-9. PubMed ID: 10971218
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes.
Arima H; Hagiwara Y; Hirayama F; Uekama K
J Drug Target; 2006 May; 14(4):225-32. PubMed ID: 16777681
[TBL] [Abstract][Full Text] [Related]
38. Effect of iron saturation level of lactoferrin on osteogenic activity in vitro and in vivo.
Wang XY; Guo HY; Zhang W; Wen PC; Zhang H; Guo ZR; Ren FZ
J Dairy Sci; 2013 Jan; 96(1):33-9. PubMed ID: 23164231
[TBL] [Abstract][Full Text] [Related]
39. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting Hypoxia and Chemotherapy-Induced Cancer Cell Metastasis under a Valid Therapeutic Effect by an Assistance of Biomimetic Oxygen Delivery.
Jiang MS; Yin XY; Qin B; Xuan SY; Yuan XL; Yin H; Zhu C; Li X; Yang J; Du YZ; Luo LH; You J
Mol Pharm; 2019 Nov; 16(11):4530-4541. PubMed ID: 31617723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
